Saba Capital Management, L.P. bought HQL
May 29, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 38,033 shares of Abrdn Life Sciences Investors at $13.09 per share, a transaction worth $497.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,033
Price
$13.09
Total value
$497.9K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 29, 2024
Filing dateMay 31, 2024
Shares owned after3,298,630
OwnershipIndirect
10b5-1 planNo
AmendedNo